THE ROLE OF INTRAPERITONEAL HYPERTHERMIC CHEMOPERFUSION IN THE COMPLEX TREATMENT OF PATIENTS WITH PERITONEAL-DISSEMINATED CANCER OF THE STOMACH
DOI:
https://doi.org/10.11603/2415-8798.2018.4.9796Keywords:
intraperitoneal hyperthermic chemoperfusion, abdominal carcinomatosis, gastric cancer, cytoreductive surgery, peritoneal carcinomatosis index, gastrectomy, survival rate, systemic chemotherapyAbstract
The combination of gastrectomy (GE), peritoneoectomy (PE) and intraperitoneal hyperthermic chemoperfusion (IPHTC) with gastric cancer (GC) is a part of a specific medical ideology, has been implemented by a group of enthusiasts united under PSOGI (Peritoneal Surface Oncology Group International – the global medical community for the study of peritoneal carcinomatosis). Over time, GE\PE\IPHTC is expected to become the standard for the combined treatment of patients with carcinomatosis in patients with gastric cancer. The experience of the Odesa Center for Reconstructive and Platic Medicine and the Odea National Medical University on the use of the method of intraperitoneal hyperthermic chemoperfusion (IPHTC) is presented in the paper. A brief prequel of some stages in the development of gastric cancer surgery was reviеwed.
The aim of the study – to consider the controversialities of world experience in the use of IPHTC (the results vary from extremly positive to rather negative), it was necessary to study the survival of patients with carcinomatosis using standard chemotherapy and HIPEC.
Materials and Methods. All in the study included 47 people who were operated in the period 2015–2017. The patients were operated at the Clinic of Reconstructive and Plastic Medicine of Odesa National Medical University. The study included only radical or conventionally radically operated patients. Average age 54.9 years, men – 14, women – 33. In order to compare the survival of patients after PE / IPHTC, a retrospective comparison group was selected, which included 22 patients with abdominal cancers, for which only intravenous systemic chemotherapy (SCh) was used.
Results and Discussion. Own observation based on the analysis of case histories of 47 patients who underwent IPHTC in stomach cancer, ovarian cancer, colorectal cancer, and some other types of malignant abdominal pathology. The survival rate of patients after HIPEC and patients with carcinomatosis of the abdominal cavity, who received only systemic chemotherapy, was compared. Survival after HIPEC was slightly worse than after systemic chemotherapy. Interest is represented by the possibility of individualization of the scheme of the IPHTC in terms of the appointment of a certain chemotheraputical drug. In this connection, the patent UA 121792 U dated 11.12.2017 is issued. Mashukov A.O., Maksimovskyi V.E., Chetverykov S.H., Lukiancuk O.V., Osadchyi D.M., Zavoloka S.O., Rosha L.H., Pyrohov V.V. Method of treating gastric cancer complicated by abdominal cavity canceromatosis. Before the procedure, a laparoscopy is carried out with a sufficient amount of material taken from the tumor tissue, followed by its immunohistochemical study on the main marker of sensitivity: TOP2A, ERCC1, TS.
Conclusions. It was concluded that, taking into account international data and data of some domestic oncology centers (Lviv Oncological Regional Center for Treatment and Diagnostic), more careful patient selection is needed based on the value of the peritoneal carcinomatosis index (PCI) and the level of planned cytoreduction.
References
Robinson, J.O., & Chir, M. (1960). The History of Gastric Surgery. Postgrad Med J., 36 (422), 706-713. PMCID: PMC2482051
Billroth, Th. (1877). Ein Beitrag zu den Operationen am Magen. Gastrorrhapie. Wien.med. Wschr., 27, 913.
Billroth, Th. (1881). Open letter to Dr. L. Wittelshofer. Wiener Medizinische Wochenschrift, 31 (1), 162-166.
Pean, J.E. (1879). De l’ablation de tumeurs de l’estomac par la gastrectomie. Gaz. Hop. (Paris), 52, 473.
Von Rydygier, L. (1880). Wyciecie raka odzwiernika zoladkowego smierc w 12 godzinach. Przeglad Lekarsky, 19, 637-640.
Von Rydygier, L. (1882). Die erste Magenresektion beim Magengeschwür. Berlin. klin. Wschr, 19, 39.
Von Rydygier, L. (1882). Bericht über die Verhandlungen der Deutschen Gesellschaft für Chirurgie. Zentralblatt für Chirurgie, 9, I98.
Connor, P.S. (1884). Report of a case of complete resection of the stomach. Med News, 45, 578.
Brigham, C.B. (1898). Case of Removal of the Entire Stomach for Carcinoma; Successful Esophagoduodenostomy; Recovery. Boston med. surg. J., 138, 415-419.
Schlatter, C. (1897). Über Ernährung und Verdauung nach vollständiger Entfernung des Magens – Oesophagoenterostomie – beim Menschen. Bruns. Beitr. Klin. Chir., 19, 757-776.
Kaula, W.J. (1896). Teaching watercolor of the components of and final placement of Murphy's button for intestinal surgical anastomosis. OnView: Digital Collections & Exhibits. Retrieved from: http://collections.countway.harvard.edu/onview/items/show/13351.
Nizri, E., Kusamura, S., & Deraco, M. (2018). Blood Transfusion in Cytoreductive Surgery: Better Not at All. Ann Surg Oncol. doi: 10.1245/s10434-018-6814-x.
Foster, J.M., Sleightholm, R., Smith, L., Ceelen, W., Deraco, M., Yildirim, Y., … & Esquivel, J. (2016-2018). Multi-Institution Evaluation of 1,051 Advanced Ovarian Cancer Patients Undergoing Cytoreductive Surgery and HIPEC: An Introduction of the Peritoneal Surface Disease Severity Score. Journal of Surgical Oncology, 114 (7), 779-784 ; 118 (4), 720.
Kusamura, S., González-Moreno, S., Nizri, E., Baratti, D., Guadagni, S., Guaglio, M., … & Deraco, M. (2018). Learning Curve, Training Program, and Monitorization of Surgical Performance of Peritoneal Surface Malignancies Centers. Surg Oncol Clin N Am., 27 (3), 507-517. doi: 10.1016/j.soc.2018.02.009.
Deraco, M., Kusamura, S., & Baratti, D. (2015). Commment on the review entitled "A critical appraisal of hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of advanced and recurrent ovarian cancer" by Chiva L. M. and Gonzalez-Martin A. Gynecol Oncol Rep,. 15, 7-8. doi: 10.1016/j.gore.2015.11.002.
Mehta, S., Schwarz, L., Spiliotis, J., Hsieh, M.C., Akaishi, E.H., Goere, D., … & Kepenekian, V. (2018). PSOGI and BIG-RENAPE Working Groups.Is there an oncological interest in the combination of CRS / HIPEC for peritoneal carcinomatosis of HCC? Results of a multicenter international study. Eur J Surg Oncol., 44 (11), 1786-1792. doi: 10.1016/j.ejso.2018.05.021.
Kopanakis, N., Argyriou, E.O., Vassiliadou, D., Sidera, C., Chionis, M., Kyriazanos, J., … & Spiliotis, J. (2018). Quality of life after cytoreductive surgery and HIPEC: A single centre prospective study. J BUON, 23 (2), 488-493.
Mirnezami, R., Mehta, A.M., Chandrakumaran, K., Cecil, T., Moran, B.J., Carr, N., … & Mirnezami, A.H. (2014). Cytoreductive surgery in combination with hyperthermic intraperitoneal chemotherapy improves survival in patients with colorectal peritoneal metastases compared with systemic chemotherapy alone. British Journal of Cancer, 111 (8), 1500-1508. doi: 10.1038/bjc.2014.419.
Ellison, L.M., Man, Y., Stojadinovic, A., Xin, H., & Avital, I. (2017). Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in treatment of gastric cancer with peritoneal carcinomatosis. Chinese Journal of Cancer Research, 29 (1), 86-92. doi: 10.21147/j.issn.1000-9604.2017.01.10.
Huang, J.Y., Xu, Y.Y., Sun, Z., Zhu, Z., Song, Y.X., Guo, P.T., … & Xu, H.M. (2012). Comparison different methods of intraoperative and intraperitoneal chemotherapy for patients with gastric cancer: a meta-analysis. Asian Pac J Cancer Prev., 13 (9), 4379-4385.
Hultman, B., Lind, P., Glimelius, B., Sundbom, M., Nygren, P., Haglund, U., & Mahteme, H. (2013). Phase II study of patients with peritoneal carcinomatosis from gastric cancer treated with preoperative systemic chemotherapy followed by peritonectomy and intraperitoneal chemotherapy. Acta Oncol., 52 (4), 824-830. doi: 10.3109/0284186X.2012.702925.
Yarema, R., Fetsych, T., Volodko, N., Оhorchak, M., Petronchak, O., Huley, R., … & Glehen, O. (2018). Evaluation of the peritoneal surface disease severity score (PSDSS) in ovarian cancer patients undergoing cytoreductive surgery and HIPEC: Two pathogenetic types based study. J Surg Oncol., 117 (8), 1806-1812. doi: 10.1002/jso.25087.
Clavien, P.A., Barkun, J., de Oliveira, M.L., Vauthey, J.N., Dindo, D., Schulick, R.D., … & Makuuchi, M. (2009). The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg., 250 (2), 187-196. doi: 10.1097/SLA.0b013e3181b13ca2.
Nakaz “Pro zatverdzhennia protokoliv nadannia medychnoi dopomohy za spetsialnistiu “onkolohiia” vid 17.09.07 r., № 554 MOZ rehlamentuye “Standarty diahnostyky ta likuvannшa onkolohichnykh khvorykh” [The Order “On approval of medical treatment protocols on the specialty “Oncology” dated September 17, 07, No. 554 of the MOH regulates the “Standards of diagnosis and treatment of cancer patients”]. Retrieved from http://search.ligazakon.ua/l_doc2.nsf/link1/MOZ7355.html [in Ukrainian].
Sugarbaker, P.H., Deraco, M., Glehen, O., Helm, C.W., Morris, D.L., & Van der Speeten, K. (2012). Cytoreductive Surgery and Perioperative Chemotherapy for Peritoneal Surface Malignancy: Textbook and Video Atlas (2nd edn.), p. 244. Product ID: CRS102.
Nizri, E., Kusamura, S., & Deraco, M. (2018). Blood Transfusion in Cytoreductive Surgery: Better Not at All. Ann Surg Oncol. doi: 10.1245/s10434-018-6814-x.
Nizri, E., Kusamura, S., Fallabrino, G., Guaglio, M., Baratti, D., & Deraco, M. (2018). Dose-Dependent Effect of Red Blood Cells Transfusion on Perioperative and Long-Term Outcomes in Peritoneal Surface Malignancies Treated with Cytoreduction and HIPEC. Ann Surg Oncol., 25 (11), 3264-3270. doi: 10.1245/s10434-018-6630-3.
Quenet, F., Elias, D., Roca, L., Goere, D., Ghouti, L., & Pocard, M. (2018). A UNICANCER phase III trial of hyperthermic intra-peritoneal chemotherapy (HIPEC) for colorectal peritoneal carcinomatosis (PC): PRODIGE 7. Journal of Clinical Oncology, 36, 18. DOI: 10.1200/JCO.2018.36.18_suppl.LBA3503
Yarema, R., Fetsych, T., Volodko, N., Оhorchak, M., & Glehen, O. (2018). Complete cytoreduction for ovarian cancer: Is it enough for long-term survival? J. Surg. Oncol., 118, 593-594.
Delbrück, H. (2007). and palliation of cancer patients. Springer-Verlag France : Springer. Paris. URL: https: //doi.org/10.1007/978-2-287-72827-3.
Horbunova, V.A., Besova, N.S., & Markovych, A.A. (2011). Likarske likuvannia raku shlunka, kolorektalnoho raku [Medicinal treatment of gastric cancer, colorectal cancer]. Vydavnytstvo: Litterra, Seriya : Praktychni kerivnytstva, p. 21 [in Ukrainian].
Baryshnikov, A.Yu., Bokhyan, B.Yu., Petrovychev, M.M., Stepanova, E.V., & Lichinitser, M.R. (2005). Tymidylat-syntetaza (TS), tymydyn-fosforylaza (TF) i dyhidropirymidyny – dehydrohenaza (DPD) pry sarkomakh miakykh tkanyn: obhruntuvannia perspektyv vykorystannia kapetsytabinu [Thymidilate synthetase (TC), thymidine phosphorylase (TF) and dihydropyrimidine dehydrogenase (DPD) with soft tissue sarcoma: rationale for the use of capecitabine]. Pytannia onkolohii – Oncology questions, 3, 314-329 [in Ukrainian].
Moliterni, A., Ménard, S., Valagussa, P., Biganzoli, E., Boracchi, P., Balsari, A. … & Bonadonna, G. (2003). HER2 Overexpression and Doxorubicin in Adjuvant Chemotherapy for Resectable Breast Cancer. Journal of Clinical Oncology, 21, 3, 458-462. doi: 10.1200/JCO.2003.04.021.
Nizri, E., Kusamura, S., & Deraco, M. (2018). Blood Transfusion in Cytoreductive Surgery: Better Not at All. Ann Surg Oncol, 73 (14), 1037-1041. doi: 10.1245/s10434-018-6814-x.
Moiseyenko, V.M., Chubenko, V.A., Moiseyenko, F.V., Zhabina, A.S., Gorodnova, T.V., Komarov, Y.I., … & Imyanitov, E.N. (2018). Dose-Dependent Effect of Red Blood Cells Transfusion on Perioperative and Long-Term Outcomes in Peritoneal Surface Malignancies Treated with Cytoreduction and HIPEC. Ann Surg Oncol., 25 (11), 3264-3270. doi: 10.1245/s10434-018-6630-3.
Kriege, M., Jager, A., Hooning, M.J., Huijskens, E., Blom, J., van Deurzen, C.H., … & Seynaeve, C. (2018). A UNICANCER phase III trial of hyperthermic intra-peritoneal chemotherapy (HIPEC) for colorectal peritoneal carcinomatosis (PC): PRODIGE 7. Journal of Clinical Oncology, 36, 18. DOI: 10.1200/JCO.2018.36.18_suppl.LBA3503
Nanda, R., Chow, L.Q., Dees, E.C., Berger, R., Gupta, S., Geva, R., ... & Buisseret, L. (2018). Complete cytoreduction for ovarian cancer: Is it enough for long-term survival? J. Surg. Oncol., 118, 593-594.
Downloads
Published
Issue
Section
License
Authors who sent their manuscript to "Вісник наукових досліджень. Bulletin of Scientific Research" Surgery agree to the following terms:
a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal. 
b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)
